Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Oral Carbohydrate Loading in Type 2 Diabetes Undergoing Gastrointestinal Surgery
NCT07830537Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Oct 2026
- Primary completion
- Nov 2027
01
Overview
Randomised, open-label trial of maltodextrin and sodium potassium magnesium calcium and glucose injection in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Homeostatic Model Assessment of Insulin Resistance. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
maltodextrinsodium potassium magnesium calcium and glucose injection
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07830537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07830537.